Naomi Holman

TL;DR: The results of this nationwide analysis in England show that type 1 and type 2 diabetes were both independently associated with a significant death with COVID-19, and the effects were attenuated to ORs of 2·86 (2·58–3·18) for type 1 diabetes and 1·80 (1·75–1·86) fortype 2 diabetes when also adjusted for previous hospital admissions with coronary heart disease, cerebrovascular disease, or heart failure.

TL;DR: Male sex, older age, renal impairment, non-white ethnicity, socioeconomic deprivation, and previous stroke and heart failure were associated with increased COVID-19-related mortality in both type 1 and type 2 diabetes.

TL;DR: A statement of diabetes prevalence in the UK showed that across the UK there were 3 333 069 people aged ≥ 17 years with a recorded diagnosis of diabetes, which equates to a prevalence of 6.2% in this age group last year.

TL;DR: Despite similar clinical characteristics and proportion of minority participants, substantial differences in metabolic control exist across the three large transatlantic registries of paediatric patients with type 1 diabetes, which appears to be due in part to the frequency of insulin pump therapy.

TL;DR: These multinational data demonstrate high rates of DKA in childhood type 1 diabetes across three registries/audits and five nations, and targeted DKA prevention programs could result in substantial health care cost reduction and reduced patient morbidity and mortality.